FDA-approved drugs in combination could provide new antibiotics
June 21, 2017Research and Development Antibiotics, FDA, antibiotic resistance
Research emerging from the University of Utah Health has built on knowledge that drugs used in combination can be more …
Novartis receives positive news in eye drug P3 studies
June 20, 2017Manufacturing and Production, Research and Development Eylea, Novartis, Regeneron
Novartis has achieved positive feedback from its two Phase 3 studies into its eye drug RTH258 (brolucizumab), which found it …
GSK’s new President of Global Pharma join date revealed as AZ drops lawsuit
June 20, 2017Business Services, Manufacturing and Production AZ, AstraZeneca, GSK, GlaxoSmithKline, Luke Miels
The transition of former AstraZeneca Executive Vice President for Europe Luke Miels to rival pharma giant GlaxoSmithKline has not been …
‘Vaccine’ to lower cholesterol enters human trials
June 20, 2017Manufacturing and Production, Research and Development AFFiRis, cholesterol, diabetes
After positive results for a ‘vaccine’ to combat fatty deposits in the arteries in mice, the researchers have taken the …
Pfizer launches vaccine study in Group B Streptococcus
June 20, 2017Manufacturing and Production, Research and Development Group B Streptococcus, Pfizer
A potentially pivotal Phase 1 study has been launched by Pfizer into the use of its investigational vaccine as a …
Merkel opens Takeda’s new production facility in Germany
June 20, 2017Manufacturing and Production Germany, Takeda, merkel
Angela Merkel was part of the opening ceremony that saw Takeda announce the completion of a third production space in …
Thermo Fisher Scientific announces single quadrupole mass spectrometer and specialised columns
June 19, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Thermo Fisher Scientific Inc., the world leader in serving science, today announced new technologies that are designed to allow analytical …
Severe asthma patients require more support, Novartis study suggests
June 19, 2017Research and Development, Sales and Marketing Novartis, asthma
A new study from Novartis has indicated that patients suffering from severe asthma still do not get adequate support to …
Sudanese research centre launches first-ever mycetoma trial
June 19, 2017Research and Development, Sales and Marketing mycetoma
A significant step forward has been made in moving towards a treatment for neglected tropical disease mycetoma as the first-ever …
Making strides in hepatitis
June 19, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Janssen, Johnson & Johnson
Pharmafocus caughtup with Lawrence Blatt, Janssen’s Global Therapeutic Area Head, Infectious Diseases and Vaccines, to discuss the progress being made in the …
Pulses of light may offer ward against mosquitos
June 19, 2017Research and Development, Sales and Marketing malaria, mosquito
Research emerging from scientists at the University of Notre Dame has found that exposing mosquitos to light during the night …
First-of-its-kind blood test unlocks precision treatment options for prostate cancer
June 19, 2017Research and Development, Sales and Marketing
AstraZeneca’s Lynparza (olparib) is making yet another impact following its impressive showing this month in the ovarian cancer space, with …
Novartis receives European biosimilar approval for Roche blockbuster
June 19, 2017Sales and Marketing Novartis, Rituxan, Rixathon, Roche
Sandoz, a division within Novartis, has received European Commission approval for its biosimilar version of Roche’s Rituxan (also known as …
Top Ten most popular articles on Pharmafile.com this week
June 16, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
The weather is heating up as we head into summer, and another week is behind us, meaning another run-down of …
Shooting for the moon: The National Cancer Institute’s Formulary
June 16, 2017Medical Communications, Research and Development NCI
Pharmafile spoke to National Cancer Institute’s (NCI) Jason Christofaro and Sherry Ansher regarding the development of an agent formulary and its role …
Drug that induces tanning could protect against melanoma
June 16, 2017Medical Communications, Research and Development melanoma, skin cancer, sun
People will often go to extraordinary lengths to achieve tanned skin but researchers have found a potential method that does …
Cambridge start-up secures £40 million to trial innovative cancer drugs
June 16, 2017Medical Communications, Research and Development, Sales and Marketing Bicycle Therapeutics, Cambridge, Cancer
Bicycle Therapeutics, a biotech start-up based in Cambridge, UK, has just raised £40 million from a range of investors including …
New rival to EpiPen receives FDA approval to shake up market
June 16, 2017Medical Communications, Sales and Marketing Adamis, Mylan, Symjepi, epipen
Adamis Pharmaceuticals has revealed that it received FDA approval for its EpiPen rival to enter the market. Its product, to …
From pipeline to patients: Navigating treatments through the UK system
June 15, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, pipeline
Pharmafocus spoke to Karen Lightning-Jones, Integrated Franchise Leader, Pipeline, to discuss the current UK climate for successfully developing drugs to …
Weakness discovered in malaria parasite could lead to new treatment
June 15, 2017Protein, anti-malarial drug resistance, malaria, mosquito
A protein has been newly discovered that could lead to an alternative form of vaccination against the spread of malaria …
Latest content
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical
Claris reports visual acuity gains with experimental LSCD treatment
Amphista doses first patient in AML trial of protein degrader
